Literature DB >> 33438273

Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours.

William J Anderson1, Leona A Doyle1.   

Abstract

The fifth edition of the World Health Organization (WHO) classification of soft tissue and bone tumours was published in May 2020. This 'Blue Book', which is also available digitally for the first time, incorporates an array of new information on these tumours, amassed in the 7 years since the previous edition. Major advances in molecular characterisation have driven further refinements in classification and the development of ancillary diagnostic tests, and have improved our understanding of disease pathogenesis. Several new entities are also included. This review summarises the main changes introduced in the 2020 WHO classification for each subcategory of soft tissue and bone tumours.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  WHO; bone; sarcoma; soft tissue; tumour

Year:  2021        PMID: 33438273     DOI: 10.1111/his.14265

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  16 in total

1.  Transcription factor c-Myb: novel prognostic factor in osteosarcoma.

Authors:  Kamila Říhová; Monika Dúcka; Iva Staniczková Zambo; Ladislava Vymětalová; Martin Šrámek; Filip Trčka; Jan Verner; Stanislav Drápela; Radek Fedr; Tereza Suchánková; Barbora Pavlatovská; Eva Ondroušková; Irena Kubelková; Danica Zapletalová; Štěpán Tuček; Peter Múdry; Dagmar Adámková Krákorová; Lucia Knopfová; Jan Šmarda; Karel Souček; Lubor Borsig; Petr Beneš
Journal:  Clin Exp Metastasis       Date:  2022-01-07       Impact factor: 5.150

2.  Prediction of recurrence-free survival and adjuvant therapy benefit in patients with gastrointestinal stromal tumors based on radiomics features.

Authors:  Fu-Hai Wang; Hua-Long Zheng; Jin-Tao Li; Ping Li; Chao-Hui Zheng; Qi-Yue Chen; Chang-Ming Huang; Jian-Wei Xie
Journal:  Radiol Med       Date:  2022-09-04       Impact factor: 6.313

3.  Delayed pulmonary metastasis and recurrence of intracranial malignant solitary fibrous tumor/hemangiopericytoma: Case report and literature review.

Authors:  Qiheng Li; Chunmei Zhang; Zhengjin Li
Journal:  Oncol Lett       Date:  2022-06-14       Impact factor: 3.111

4.  Safety and effectiveness of eribulin in Japanese patients with soft tissue sarcoma including rare subtypes: a post-marketing observational study.

Authors:  Akira Kawai; Hiroyuki Narahara; Shunji Takahashi; Tomoki Nakamura; Hiroshi Kobayashi; Yasunori Megumi; Toshiyuki Matsuoka; Eisuke Kobayashi
Journal:  BMC Cancer       Date:  2022-05-11       Impact factor: 4.638

5.  Primary liposarcoma of the omentum: A case report.

Authors:  Ying Gao; Yujie Qin; Yingchao Wang; Xiaoling Quan; Xiaoyi Wei; Jiaxi Yao
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

6.  Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer.

Authors:  Danh D Truong; Salah-Eddine Lamhamedi-Cherradi; Joseph A Ludwig
Journal:  J Bone Oncol       Date:  2022-02-24       Impact factor: 4.072

7.  Stemness Subtypes and Scoring System Predict Prognosis and Efficacy of Immunotherapy in Soft Tissue Sarcoma.

Authors:  Hui-Yun Gu; Wen-Qiang Qu; Hai-Heng Peng; Yi-Feng Yu; Zhe-Zhen Jiang; Bai-Wen Qi; Ai-Xi Yu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

Review 8.  Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice.

Authors:  Chiara Agnoletto; Chiara Caruso; Cecilia Garofalo
Journal:  Cancers (Basel)       Date:  2021-05-02       Impact factor: 6.639

9.  Treatment of Pediatric Inflammatory Myofibroblastic Tumor: The Experience from China Children's Medical Center.

Authors:  Youhong Dong; Kashif Rafiq Zahid; Yidi Han; Pengchao Hu; Dongdong Zhang
Journal:  Children (Basel)       Date:  2022-02-24

10.  Primary renal sarcomas: imaging features and discrimination from non-sarcoma renal tumors.

Authors:  Johannes Uhlig; Annemarie Uhlig; Sophie Bachanek; Mehmet Ruhi Onur; Sonja Kinner; Dominik Geisel; Michael Köhler; Heike Preibsch; Michael Puesken; Dominik Schramm; Matthias May; Pieter De Visschere; Marc-André Weber; Alexey Surov
Journal:  Eur Radiol       Date:  2021-07-31       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.